Month: March 2020

AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen as a Potential Protective and Early-Onset Treatment for the Current COVID-19 Pandemic

OCALA, FL / ACCESSWIRE / March 26, 2020 / AIM ImmunoTech (NYSE American:AIM) today announced that it is actively seeking investigators...

LivaNova Autonomic Regulation Therapy for Heart Failure Findings to be Presented at American College of Cardiology and World Congress of Cardiology Virtual Meeting

LONDON--(BUSINESS WIRE)--$LIVN--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced two abstracts focused on implantable neuromodulation technology...

NeuroRx to discuss investigational drug for COVID-19 related Acute Respiratory Distress at Solebury Trout Virtual Global Healthcare Conference on March 26, 2020

NeuroRx is leading US development of RLF-100 (Aviptadil) on behalf of Relief Therapeutics' (RLF) WILMINGTON, DE and RADNOR, PA /...

error: Content is protected !!